Coloplast EPS - Earnings per Share 2014-2025 | CLPBY
Coloplast annual and quarterly earnings per share history from 2014 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Coloplast EPS for the quarter ending September 30, 2025 was $0.06, a 29.07% decline year-over-year.
- Coloplast EPS for the twelve months ending September 30, 2025 was $0.24, a 27.22% decline year-over-year.
- Coloplast 2025 annual EPS was $0.24, a 26.91% decline from 2024.
- Coloplast 2024 annual EPS was $0.33, a 2.83% increase from 2023.
- Coloplast 2023 annual EPS was $0.32, a 1.24% decline from 2022.
| Coloplast Annual EPS | |
|---|---|
| 2025 | $0.24 |
| 2024 | $0.33 |
| 2023 | $0.32 |
| 2022 | $0.32 |
| 2021 | $0.36 |
| 2020 | $0.30 |
| 2019 | $0.28 |
| 2018 | $0.29 |
| 2017 | $0.27 |
| 2016 | $0.22 |
| 2015 | $0.00 |
| Coloplast Quarterly EPS | |
|---|---|
| 2025-09-30 | $0.06 |
| 2025-06-30 | $0.05 |
| 2025-03-31 | $0.06 |
| 2024-12-31 | $0.07 |
| 2024-09-30 | $0.09 |
| 2024-06-30 | $0.08 |
| 2024-03-31 | $0.08 |
| 2023-12-31 | $0.08 |
| 2023-09-30 | $0.08 |
| 2023-06-30 | $0.09 |
| 2023-03-31 | $0.08 |
| 2022-12-31 | $0.07 |
| 2022-09-30 | $0.08 |
| 2022-06-30 | $0.09 |
| 2022-03-31 | $0.07 |
| 2021-12-31 | $0.09 |
| 2021-09-30 | $0.10 |
| 2021-06-30 | $0.10 |
| 2021-03-31 | $0.09 |
| 2020-12-31 | $0.09 |
| 2020-09-30 | $0.08 |
| 2020-06-30 | $0.07 |
| 2020-03-31 | $0.07 |
| 2019-12-31 | $0.08 |
| 2019-09-30 | $0.06 |
| 2019-06-30 | $0.08 |
| 2019-03-31 | $0.07 |
| 2018-12-31 | $0.07 |
| 2018-09-30 | $0.08 |
| 2018-06-30 | $0.07 |
| 2018-03-31 | $0.07 |
| 2017-12-31 | $0.07 |
| 2017-09-30 | $0.08 |
| 2017-06-30 | $0.06 |
| 2017-03-31 | $0.06 |
| 2016-12-31 | $0.07 |
| 2016-09-30 | $0.00 |
| 2015-12-31 | $0.06 |
| 2014-06-30 | $0.05 |
| 2014-03-31 | $0.00 |
| 2013-12-31 | $0.07 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $18.886B | $4.130B |
| Coloplast A/S engages in the development and sale of intimate healthcare products and services principally in Denmark, the United States, the United Kingdom, France and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology and Advanced Wound Care segments. Coloplast A/S is based in Humleb?k, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $203.769B | 23.72 |
| Intuitive Surgical (ISRG) | United States | $169.156B | 65.25 |
| IDEXX Laboratories (IDXX) | United States | $51.392B | 49.24 |
| Edwards Lifesciences (EW) | United States | $45.321B | 30.39 |
| Alcon (ALC) | Switzerland | $38.763B | 26.12 |
| IQVIA Holdings (IQV) | United States | $30.817B | 16.65 |
| Mettler-Toledo (MTD) | United States | $28.249B | 32.32 |
| DexCom (DXCM) | United States | $27.258B | 37.58 |
| STERIS (STE) | Ireland | $23.929B | 24.19 |
| Waters (WAT) | United States | $22.443B | 29.68 |
| Hologic (HOLX) | United States | $16.676B | 17.45 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.939B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.116B | 11.71 |
| Penumbra (PEN) | United States | $13.394B | 94.22 |
| Globus Medical (GMED) | United States | $11.711B | 24.58 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.269B | 23.29 |
| Glaukos (GKOS) | United States | $6.520B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.967B | 18.96 |
| Teleflex (TFX) | United States | $4.680B | 7.46 |
| TransMedics (TMDX) | United States | $4.429B | 52.47 |
| LivaNova (LIVN) | United Kingdom | $3.551B | 19.18 |
| Integer Holdings (ITGR) | United States | $2.986B | 14.02 |
| Veracyte (VCYT) | United States | $2.756B | 31.41 |
| Elekta AB (EKTAY) | Sweden | $2.223B | 20.79 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 22.64 |
| Alphatec Holdings (ATEC) | United States | $2.005B | 0.00 |
| UFP Technologies (UFPT) | United States | $1.976B | 26.09 |
| Artivion (AORT) | United States | $1.869B | 85.78 |
| AxoGen (AXGN) | United States | $1.564B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.531B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.284B | 0.00 |
| IRadimed (IRMD) | United States | $1.203B | 57.30 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.928B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.847B | 4.59 |
| SiBone (SIBN) | United States | $0.682B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.643B | 12.82 |
| Tactile Systems Technology (TCMD) | United States | $0.608B | 35.34 |
| Beta Bionics (BBNX) | United States | $0.583B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.582B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.518B | 0.00 |
| NeuroPace (NPCE) | United States | $0.516B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.504B | 13.12 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.503B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.416B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.357B | 0.00 |
| RxSight (RXST) | United States | $0.322B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.316B | 52.59 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.158B | 0.00 |
| Inogen (INGN) | United States | $0.154B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.150B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.130B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.116B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.109B | 0.00 |
| Hyperfine (HYPR) | United States | $0.101B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Accuray (ARAY) | United States | $0.068B | 0.00 |
| DarioHealth (DRIO) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.059B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.046B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.016B | 0.00 |
| Envoy Medical (COCH) | United States | $0.015B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| NexGel (NXGL) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |